Clinical Research: Trials Coordinated (2 of 2)

A 20-week, multi-center, randomized, double-blind placebo controlled, preliminary study to evaluate the safety and efficacy of two fixed doses of a cholinesterase inhibitor in migraine prophylaxis.

A randomized, double blind, placebo controlled trial to evaluate the safety and efficacy of a cholinesterase inhibitor in subjects with mild cognitive impairment (MCI) clinically at risk for development of probable Alzheimer’s disease.

A randomized, double blind, placebo controlled, parallel group trial to assess the efficacy and safety of an anti-epileptic in the prophylaxis of migraine.

A multi-center, randomized, double blind placebo controlled parallel group trial to assess the efficacy of a triptan in the acute treatment of a migraine during the mild intensity phase of an attack in patients highly disabled by migraine.

A double blind, placebo controlled, two attack cross-over study to assess the efficacy of a triptan in the acute treatment for mild migraine headache.

An open-label evaluation of the long-term safety of a 5HT, receptor agonist as short-term prophylactic treatment for menstrually associated migraine.

A randomized, double blind, placebo controlled single, crossover study to compare effects of two medications used to treat overactive bladder and placebo on cognitive function in healthy elderly subjects.

A multi-center, randomized, double-blind, parallel group, single dose, placebo controlled study of the efficacy and safety of a combination medication in subjects with acute migraine attacks.

An OTC plus sinus medication vs. OTC vs. triptan in migraine headache study.

A double blind, placebo-controlled study to evaluate the efficacy of Amantadine in the prevention and treatment of Influenza A.

A four-year study sponsored by the National Institutes of Health on the safety and efficacy of an influenza vaccine in the form on Nose Drops in Children and Adults. Flu 1 / Flu 2

A four-year study sponsored by the National Institutes of Health on the safety and efficacy of a rotavirus vaccine in children and adults. Rota 1

 

Contact Information

Paul Eric Kilmon
Phone: 443.739.2518
Email: paerki@hotmail.com

Availability

I am looking for full or part-time employment. I will consider relocating. I am also interested in volunteer work.

Interests

Paul Kilmon: Career Copyright © 2009 Community is Designed by Bie Blogger Template (Redesigned by PAERKI)